This brand name is authorized in Lithuania, United States
The drug AVANDIA contains one active pharmaceutical ingredient (API):
1
Rosiglitazone
UNII KX2339DP44 - ROSIGLITAZONE MALEATE
|
Rosiglitazone is a selective agonist at the PPARγ (peroxisomal proliferator activated receptor gamma) nuclear receptor and is a member of the thiazolidinedione class of anti-diabetic agents. It reduces glycaemia by reducing insulin resistance at adipose tissue, skeletal muscle and liver. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
AVANDIA Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
AVANDIA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A10BG02 | Rosiglitazone | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BG Thiazolidinediones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004060, 1004061, 1008706, 1008707, 1008708, 1026578, 1026579, 1026580, 1026581, 1026582, 1026583, 1026584, 1026585, 1026586, 1026587, 1026588, 1026589, 1026590 |
Country: US | FDA, National Drug Code | Identifier(s): 0173-0861, 0173-0863 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.